Cellectis SA ADR buy Quitte
Start price
29.02.16
/
50%
€21.07
Target price
18.03.16
€24.35
Performance (%)
15.63%
End price
18.03.16
€24.36
Summary
This prediction ended on 18.03.16 with a price of €24.36. The BUY prediction by Quitte finished with a performance of 15.63%. Quitte has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Cellectis SA ADR | -4.138% | -4.138% | 143.860% | 54.444% |
| iShares Core DAX® | -1,74 % | -10,68 % | -0,89 % | 48,09 % |
| iShares Nasdaq 100 | -2,58 % | -3,32 % | 11,12 % | 74,13 % |
| iShares Nikkei 225® | -1,16 % | -9,36 % | 23,69 % | 48,88 % |
| iShares S&P 500 | -1,42 % | -3,76 % | 7,19 % | 57,43 % |
Comments by Quitte for this prediction
In the thread Cellectis SA ADR diskutieren
gutes Rating und eventuell ein Boden
Shares of Cellectis SA (NASDAQ:CLLS) have received a consensus broker rating score of 1.00 (Strong Buy) from the four brokers that provide coverage for the stock, Zacks Investment Research reports. Four analysts have rated the stock with a strong buy recommendation.